• All Share : 49329.98
    UP 0.08%
    Top 40 : 3478.29
    UP 0.04%
    Financial 15 : 15437.98
    DOWN -0.36%
    Industrial 25 : 61816.58
    UP 0.06%

  • ZAR/USD : 11.5888
    UP 0.33%
    ZAR/GBP : 18.1495
    UP 0.31%
    ZAR/EUR : 14.2360
    UP 0.30%
    ZAR/JPY : 0.0972
    UP 0.12%
    ZAR/AUD : 9.4746
    UP 0.42%

  • Gold : 1197.0500
    UP 0.07%
    Platinum : 1199.5000
    UP 0.13%
    Silver : 15.9100
    UP 0.38%
    Palladium : 795.5000
    UP 0.82%
    Brent Crude Oil : 60.400
    UP 1.91%

  • All data is delayed by 15 min. Data supplied by I-Net Bridge
    Hover cursor over this ticker to pause.

Fri Dec 19 16:19:53 SAST 2014

Patents 'spike drug prices'

KATHARINE CHILD | 27 February, 2013 00:06

Image by: Gallo Images/Thinkstock

The Treatment Action Campaign and Médecins Sans Frontières say medicine prices in South Africa are among the highest in the world.

They blame the patenting system, which they say makes it easy to patent new changes to existing drugs.

They two organisations protested at the Africa Intellectual Property conference in Midrand yesterday.

In South Africa, patents are granted automatically but can be challenged in court .

Médecins Sans Frontières' lawyer, Leena Menghaney, said the organisation managed to get a patent revoked in India for cancer drug imatinib.

It is now produced by generic companies in India for R46 a tablet. It could not be repatented in that country because the pharmaceutical company had made only a minor change to the original compound.

In South Africa, imatinib is patented and costs about R893 a tablet.

Although the main drug patent for imatinib expired this year, a new patent kept it protected in South Africa until 2029, said Menghaney.

The NGOs want a patent examination office that examines patents before granting them.

University of Pretoria law professor Esme du Plessis said an examination office might slow down the granting of patents by years.

In Japan, granting a patent took about nine years because of the use of an examination office, she said.


If you have an opinion you would like to share on this article, please send us an e-mail to the Times LIVE iLIVE team. In the mean time, click here to view the Times LIVE iLIVE section.